iTAC Software AG: Closed Loop: Simulating, planning and managing the digital factory
24.5.2023 14:48:14 CEST | news aktuell GmbH | Press release
The factory of the future is digital and relies on integrated, rather than isolated, solutions. The software companies DUALIS GmbH IT Solution (www.dualis-it.de) and iTAC Software AG (www.itacsoftware.com) developed a holistic digitalization approach for greater efficiency, flexibility and quality in manufacturing. In the closed loop model, simulation, APS and MES/MOM are closely interlinked and interact with each other. This means, for example, that manufacturing processes can be optimized end-to-end. At the same time, costs and risks can be minimized.
One element of the holistic digitization approach is the digital twin. Using the 3D simulation platform Visual Components, which is supplied by DUALIS, users can create digital twins of their entire production and simulate material and process flows. This allows systems, components, and processes to be tested before they are used in practice, "what-if" scenarios to be run through and errors to be minimized.
Based on these simulation results, a model for realistic production planning can be generated with the GANTTPLAN advanced planning and scheduling system (APS) from DUALIS. The APS carries out planning across departments and takes the entire value chain into account.
At the same time, the data from the digital twin is transferred directly to iTAC Software AG's iTAC.MOM.Suite manufacturing operations management system. This forms the necessary interface between production and IT systems and enables real-time monitoring of production processes. If the MOM knows the current state, the APS can precisely calculate the future.
This marks the closed loop approach: the real data from the MOM and APS system is sent back to the simulation for continuous optimization of the process flows. Changes in key figures and throughputs can then be viewed and evaluated.
iTAC Software AG
Alina Leber
+(49)26021065211
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
IFR - International Federation of Robotics: Global Sales of Professional Service Robots Surge 24%30.9.2026 12:05:00 CEST | Press release
7,000 Humanoids emerge as new market 117,000 Transport and logistics’ robots lead as top application
MED-EL Launches World’s First Commercially Available Totally Invisible Cochlear Implant29.9.2026 14:00:00 CEST | Press release
World's first and only commercially available cochlear implant with all components implanted beneath the skin Continuous hearing day and night Hearing performance designed to be the same as established cochlear implant solutions
Strong international interest in Security Essen and EUDEX24.9.2026 09:14:52 CEST | Press release
From Albania to Uzbekistan – visitors from almost 90 nations Trade visitors from 89 nations to date, international delegations and companies from more than 40 countries: Security Essen and the new Euro Defence Expo (EUDEX) are bringing guests from numerous parts of the world to Messe Essen this week. Visitors from the Netherlands, Belgium, Switzerland, the UK, Poland, the Czech Republic and France are particularly well represented. But experts are also travelling from more distant countries such as Argentina, Ukraine, Singapore and South Korea to network across borders and find out about the latest security and defence technologies. Security Essen focuses on civil security, whilst the inaugural EUDEX is dedicated to the defence industry.
Major update for Thermomix® and Cookidoo®¬– ecosystem gets smarter, more personalised and more global21.9.2026 13:47:30 CEST | Press release
Thermomix® takes its ecosystem to the next level: With the new Cookidoo® Assistant and Recipe Translation benefits, the largest culinary community gains comprehensive AI features. In addition, Arabic is introduced as a new language option on Thermomix® TM7, following a long-standing community demand.
Grünenthal acquires cancer treatment Stivarga®21.9.2026 12:36:25 CEST | Press release
Latest step in Grünenthal’s strategy to acquire established medicines that serve clear medical needs, leverage its commercial and operational capabilities, and drive growth. Stivarga® (regorafenib) is an established oral treatment for certain advanced cancers, including metastatic colorectal cancer, gastrointestinal stromal tumours (GIST) and hepatocellular carcinoma (liver cancer). It is approved and available in more than 90 markets worldwide. Grünenthal has invested around €2.6 billion in successful M&A transactions since 2017, significantly strengthening its profitability and further funding its innovative research pipeline.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom